Arbutus Biopharma Corp (ABUS) is around the top of the Biotechnology industry according to InvestorsObserver. ABUS received an overall rating of 46, which means that it scores higher than 46 percent of all stocks. Arbutus Biopharma Corp also achieved a score of 77 in the Biotechnology industry, putting it above 77 percent of Biotechnology stocks. Biotechnology is ranked 109 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 46 would rank higher than 46 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Arbutus Biopharma Corp Stock Today?
Arbutus Biopharma Corp (ABUS) stock is up 3.35% while the S&P 500 is lower by -0.27% as of 2:11 PM on Monday, Jun 14. ABUS is up $0.11 from the previous closing price of $3.28 on volume of 830,726 shares. Over the past year the S&P 500 is higher by 38.13% while ABUS is up 84.24%. ABUS lost -$0.96 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Arbutus Biopharma Corp (ABUS) Stock.